FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The company plans to refile its application for its gene therapy for a fatal brain disease after the FDA dropped demands to give a placebo to some study subjects.
Connecting Global Economies
The company plans to refile its application for its gene therapy for a fatal brain disease after the FDA dropped demands to give a placebo to some study subjects.
Microsoft’s CEO offers a blistering critique of the AI power balance and calls for earning society’s permission.
Coowa’s valuation stood at more than $3 billion after it raised more than $600 million in its latest funding round, people familiar with the matter said.
The opportunities for entry-level employees are new and different.
By micromanaging platforms, the White House picks winners and losers.
Plus, the hacker sent to calm the U.S. government’s nerves about AI, the surprising benefits of 3-D-printed batteries, Elon’s $86 billion war chest and more.
Socialists claim they haven’t experienced American prosperity. All you have to do is look around.
As companies move quickly to adapt artificial intelligence, there are some areas where it may do more harm than good.
With prices of new tech on the rise, the refurbished market never looked so good.
Prices are rising on smartphones, game consoles, laptops and more.